| abstract |
There is disclosed a pharmaceutical composition for inhibiting platelet aggregation comprising 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine or a pharmaceutically acceptable salt thereof and a 1,5-benzothiazepine derivative of the formula: <CHEM> wherein R<1> is a lower alkyl group or a lower alkoxy group, R<2> is a lower alkanoyl group, R<3> and R<4> are a lower alkyl group and R<5> is hydrogen atom, a lower alkyl group or a halogen atom, or a pharmaceutically acceptable salt thereof. |